THE BONE PARADOX IN DIABETES: PRESERVED BONE MINERAL DENSITY AND INCREASED FRACTURE RISK

Diabetes mellitus is associated with an increased risk of fragility fractures, including hip, nonvertebral, and vertebral fractures, a finding that contrasts with the normal or even elevated bone mineral density frequently observed in people with type 2 diabetes. This apparent contradiction, described as the bone paradox of diabetes, indicates that bone mass measured by dual-energy X-ray absorptiometry captures only part of skeletal strength and that factors related to bone quality, bone turnover, microvascular disease, falls, and pharmacological treatment contribute to fragility. This review aimed to analyze the mechanisms that explain the dissociation between bone mineral density and fracture risk in diabetes and to discuss its implications for fracture risk assessment and clinical management. This is a narrative literature review, guided by a structured question based on the PICo strategy and directed at studies on bone health in adults with type 1 or type 2 diabetes. The evidence shows that fracture risk is higher in type 1 diabetes and moderately elevated in type 2 diabetes, and that, for the same T-score or FRAX estimate, people with diabetes fracture more often than those without the disease. Accumulation of advanced glycation end-products in collagen, low bone turnover, cortical porosity associated with microvascular disease, hypoglycemia, and fall risk help explain this excess risk. Adjustments to FRAX, the use of trabecular bone score, and systematic screening for vertebral fractures improve risk identification, while available osteoporosis therapies appear to retain their effect on bone mineral density in this population. It is concluded that bone fragility should be recognized as a chronic complication of diabetes, requiring risk assessment adapted to the disease and integration between metabolic and skeletal care.

Authors

Institutions

Publication Details

Journal
Artefactum
Published
2026-11-16
DOI
https://doi.org/10.23900/artefactum.v25i14.010
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

THE BONE PARADOX IN DIABETES: PRESERVED BONE MINERAL DENSITY AND INCREASED FRACTURE RISK

Pedro Henrique Lima Domingues, Paula Masi, José Antonio Pizzolato Neto, Felipe Ravazzi Guzzo et al.
Artefactum
Bone health and osteoporosis research
article

THE BONE PARADOX IN DIABETES: PRESERVED BONE MINERAL DENSITY AND INCREASED FRACTURE RISK

Pedro Henrique Lima Domingues, Paula Masi, José Antonio Pizzolato Neto, Felipe Ravazzi Guzzo, Cristiano Machado Galhardi, Manuela Mello Guerra, Sophia Evaristo Coércio, Luan Tavares Amadeu, Letícia Cher Messias Pavoni, João Victor Laiola De Oliveira Barbosa, Henrique Marins Cisneros, Rodolfo de Oliveira Medeiros, Rafael Ignacio, Beatriz Camilly Fernandes
article en

Abstract

Diabetes mellitus is associated with an increased risk of fragility fractures, including hip, nonvertebral, and vertebral fractures, a finding that contrasts with the normal or even elevated bone mineral density frequently observed in people with type 2 diabetes. This apparent contradiction, described as the bone paradox of diabetes, indicates that bone mass measured by dual-energy X-ray absorptiometry captures only part of skeletal strength and that factors related to bone quality, bone turnover, microvascular disease, falls, and pharmacological treatment contribute to fragility. This review aimed to analyze the mechanisms that explain the dissociation between bone mineral density and fracture risk in diabetes and to discuss its implications for fracture risk assessment and clinical management. This is a narrative literature review, guided by a structured question based on the PICo strategy and directed at studies on bone health in adults with type 1 or type 2 diabetes. The evidence shows that fracture risk is higher in type 1 diabetes and moderately elevated in type 2 diabetes, and that, for the same T-score or FRAX estimate, people with diabetes fracture more often than those without the disease. Accumulation of advanced glycation end-products in collagen, low bone turnover, cortical porosity associated with microvascular disease, hypoglycemia, and fall risk help explain this excess risk. Adjustments to FRAX, the use of trabecular bone score, and systematic screening for vertebral fractures improve risk identification, while available osteoporosis therapies appear to retain their effect on bone mineral density in this population. It is concluded that bone fragility should be recognized as a chronic complication of diabetes, requiring risk assessment adapted to the disease and integration between metabolic and skeletal care.

ArtefactumVol. 25(14)
Universidade de Marília (BR)
Good health and well-being
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon